š§
Pfizer's Lyme Disease Vaccine Shows 70% Efficacy
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.